They reported that patients with lung adenocarcinoma exhibiting a high expression level of Keap1 and a low expression level of Nrf2 had significantly better overall survival and disease-free survival than patients exhibiting a low expression level of Keap1 and a high expression level of Nrf2 (10). The gene discussed is NFE2L2; the disease is lung adenocarcinoma.